This partnership encompasses dossier licensing, bulk product supply, and the licensing of ZIM Labs’ proprietary Oral Thin Film technology platform, ThinOral
The company plans to add 1700 beds by FY27 through the organic route
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
Both the India and GCC entities will be operated by separate dedicated management teams
Dr. Peter Houghton will lead the research collaboration for GCCRI and is widely regarded as a leading expert in pediatric cancer research and in the development of novel approaches to treating childhood cancers
This certification will open new markets for the Kwality Pharma
Aster DM Healthcare and Quality Care India Limited have signed definitive agreements to merge, subject to regulatory, corporate and shareholders’ approvals
This agreement reinforces Lubrizol’s commitment to Make-In-India and broadens a previously committed US$ 350 million investment to support local manufacturing
Q1 FY25 revenues up 20% YoY to Rs. 1,002 crore
Subscribe To Our Newsletter & Stay Updated
